Literature DB >> 15809330

The FLI-1 transcription factor is a short-lived phosphoprotein in T cells.

Xian K Zhang1, Dennis K Watson.   

Abstract

The FLI-1 transcription factor is a member of the ETS gene family, most closely related to ERG. In this study, the FLI-1 protein products were characterized using a specific monoclonal antibody previously developed against bacterially expressed protein. In the human T-cell line Jurkat, both isoforms of FLI-1, p51 and p48, are phosphorylated, primarily on serine residues. FLI-1 phosphorylation is increased by a Ca(2+)-mediated process, and inhibitor studies indicate that protein phosphatase 2A, at least in part, controls FLI-1 phosphorylation level. FLI-1 phosphorylation is not stimulated by phorbal 12-myristate 13-acetate (PMA), a protein kinase C activator, and in this it differs from ERG protein phosphorylation. The p51 isoform has a half-life of 105 min, and p48 has a half-life of 80 min; in contrast, the ERG protein is much more stable with a half-life of 21 h. Newly synthesized FLI-1 protein decreased during human T cell activation. Our data suggest that although the FLI-1 and ERG genes are highly homologous, their distinct properties may contribute to their different roles in gene regulation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15809330     DOI: 10.1093/jb/mvi032

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  12 in total

Review 1.  The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis.

Authors:  Yoshihide Asano; Andreea M Bujor; Maria Trojanowska
Journal:  J Dermatol Sci       Date:  2010-07-03       Impact factor: 4.563

2.  Fli-1 transcription factor regulates the expression of caspase-1 in lung pericytes.

Authors:  Pengfei Li; Andrew J Goodwin; James A Cook; Perry V Halushka; Xian K Zhang; Hongkuan Fan
Journal:  Mol Immunol       Date:  2019-02-08       Impact factor: 4.407

3.  Fli-1 Governs Pericyte Dysfunction in a Murine Model of Sepsis.

Authors:  Pengfei Li; Yue Zhou; Andrew J Goodwin; James A Cook; Perry V Halushka; Xian K Zhang; Carole L Wilson; Lynn M Schnapp; Basilia Zingarelli; Hongkuan Fan
Journal:  J Infect Dis       Date:  2018-11-05       Impact factor: 5.226

4.  Marinobufagenin induces increases in procollagen expression in a process involving protein kinase C and Fli-1: implications for uremic cardiomyopathy.

Authors:  Jihad Elkareh; Sankaridrug M Periyasamy; Amjad Shidyak; Sandeep Vetteth; Jeremy Schroeder; Vanamala Raju; Imad M Hariri; Nasser El-Okdi; Shalini Gupta; Larisa Fedorova; Jiang Liu; Olga V Fedorova; M Bashar Kahaleh; Zijian Xie; Deepak Malhotra; Dennis K Watson; Alexei Y Bagrov; Joseph I Shapiro
Journal:  Am J Physiol Renal Physiol       Date:  2009-03-04

5.  The transcription factor Fli-1 modulates marginal zone and follicular B cell development in mice.

Authors:  Xian K Zhang; Omar Moussa; Amanda LaRue; Sarah Bradshaw; Ivan Molano; Demetri D Spyropoulos; Gary S Gilkeson; Dennis K Watson
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

6.  O-GlcNAcylation is involved in the transcriptional activity of EWS-FLI1 in Ewing's sarcoma.

Authors:  R Bachmaier; D N T Aryee; G Jug; M Kauer; M Kreppel; K A Lee; H Kovar
Journal:  Oncogene       Date:  2009-01-19       Impact factor: 9.867

7.  Phosphorylation of Fli1 at threonine 312 by protein kinase C delta promotes its interaction with p300/CREB-binding protein-associated factor and subsequent acetylation in response to transforming growth factor beta.

Authors:  Yoshihide Asano; Maria Trojanowska
Journal:  Mol Cell Biol       Date:  2009-01-21       Impact factor: 4.272

8.  Ets factors and a newly identified polymorphism regulate Fli1 promoter activity in lymphocytes.

Authors:  Tamara K Nowling; Jennifer Dziadyk Fulton; Katherine Chike-Harris; Gary S Gilkeson
Journal:  Mol Immunol       Date:  2007-07-02       Impact factor: 4.407

9.  Drug-mediated inhibition of Fli-1 for the treatment of leukemia.

Authors:  Y-J Li; X Zhao; L M Vecchiarelli-Federico; Y Li; A Datti; Y Cheng; Y Ben-David
Journal:  Blood Cancer J       Date:  2012-01-27       Impact factor: 11.037

10.  Important genes in the pathogenesis of 5q- syndrome and their connection with ribosomal stress and the innate immune system pathway.

Authors:  Ota Fuchs
Journal:  Leuk Res Treatment       Date:  2012-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.